Press 2024

May 30, 2024

Lummus Launches Renewable Dimethyl Ether Technology

Now commercially available, the technology leverages best-in-class and proven processes to help customers meet sustainability needs

HOUSTON, May 30, 2024 – Lummus Technology, a global provider of process technologies and value-driven energy solutions, announced the commercial availability of CDDMESM, a new renewable dimethyl ether (DME) technology that is enhanced through catalytic distillation (CD).

“Lummus has a leading market position and extensive commercial experience in ethers production, from small specialty applications to world-scale production units with challenging feedstocks,” said Ron Venner, Chief Business Officer of Clean Fuels, Lummus Technology. “Our experience underlies this renewable DME technology, providing customers with a clean, flexible and cost-effective solution that will help them meet current and future demands for sustainable fuels and chemicals.”

The CDDME technology can process numerous types of methanol to produce renewable DME, which can then be blended to produce liquefied petroleum gas or used as a hydrogen carrier. The technology requires fewer unit operations, generates high conversion rates, and reduces utility and operating costs, resulting in lower CAPEX and OPEX.

Lummus is the industry’s leading licensor for ether technology using catalytic distillation. Lummus’ CD portfolio includes more than 25 technologies, catalysts and proprietary equipment, with more than 200 licensed units in the refining and petrochemical industries.

About Lummus Technology
Lummus Technology is the global leader in developing technology solutions that make modern life possible and focus on a more sustainable, low carbon future. We license process technologies in clean fuels, renewables, petrochemicals, polymers, gas processing and supply lifecycle services, catalysts, proprietary equipment and digitalization to customers worldwide. To learn more about Lummus, visit

Lummus Technology
Matt Braud

Marketing and Communications
+1 281 368 3116 (direct)

+1 225 335 3392 (cell)
[email protected]